Marks HG - Search Results

1

Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.

Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A. Valencia I, et al. Among authors: marks hg. Eur J Paediatr Neurol. 2009 Mar;13(2):141-5. doi: 10.1016/j.ejpn.2008.03.002. Epub 2008 Jun 27. Eur J Paediatr Neurol. 2009. PMID: 18585941

2

Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.

Kothare SV, Khurana DS, Mostofi N, Melvin JJ, Marks HG, Valencia I, Legido A. Kothare SV, et al. Among authors: marks hg. Pediatr Neurol. 2006 Oct;35(4):235-9. doi: 10.1016/j.pediatrneurol.2006.02.009. Pediatr Neurol. 2006. PMID: 16996394

3

Efficacy and tolerability of topiramate in pediatric migraine.

Cruz MJ, Valencia I, Legido A, Kothare SV, Khurana DS, Yum S, Hardison HH, Melvin JJ, Marks HG. Cruz MJ, et al. Among authors: marks hg. Pediatr Neurol. 2009 Sep;41(3):167-70. doi: 10.1016/j.pediatrneurol.2009.04.020. Pediatr Neurol. 2009. PMID: 19664530

4

Microarray analysis in children with developmental disorder or epilepsy.

Ezugha H, Anderson CE, Marks HG, Khurana D, Legido A, Valencia I. Ezugha H, et al. Among authors: marks hg. Pediatr Neurol. 2010 Dec;43(6):391-4. doi: 10.1016/j.pediatrneurol.2010.06.019. Pediatr Neurol. 2010. PMID: 21093728

5

Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies.

Khurana DS, Salganicoff L, Melvin JJ, Hobdell EF, Valencia I, Hardison HH, Marks HG, Grover WD, Legido A. Khurana DS, et al. Among authors: marks hg. Neuropediatrics. 2008 Feb;39(1):8-13. doi: 10.1055/s-2008-1076737. Neuropediatrics. 2008. PMID: 18504675

6

Treatment of drop attacks in Coffin-Lowry syndrome with the use of sodium oxybate.

Havaligi N, Matadeen-Ali C, Khurana DS, Marks H, Kothare SV. Havaligi N, et al. Pediatr Neurol. 2007 Nov;37(5):373-4. doi: 10.1016/j.pediatrneurol.2007.06.025. Pediatr Neurol. 2007. PMID: 17950427

7

Sleep study abnormalities in children with attention deficit hyperactivity disorder.

Goraya JS, Cruz M, Valencia I, Kaleyias J, Khurana DS, Hardison HH, Marks H, Legido A, Kothare SV. Goraya JS, et al. Pediatr Neurol. 2009 Jan;40(1):42-6. doi: 10.1016/j.pediatrneurol.2008.09.007. Pediatr Neurol. 2009. PMID: 19068253

8

Subacute sclerosing panencephalitis (SSPE) presenting as acute disseminated encephalomyelitis in a child.

Goraya J, Marks H, Khurana D, Legido A, Melvin J. Goraya J, et al. J Child Neurol. 2009 Jul;24(7):899-903. doi: 10.1177/0883073808330184. Epub 2009 Feb 9. J Child Neurol. 2009. PMID: 19204320

9

5q14.3 deletion manifesting as mitochondrial disease and autism: case report.

Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H. Ezugha H, et al. J Child Neurol. 2010 Oct;25(10):1232-5. doi: 10.1177/0883073809361165. Epub 2010 Feb 22. J Child Neurol. 2010. PMID: 20179003

10

Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis.

Goldenthal MJ, Damle S, Sheth S, Shah N, Melvin J, Jethva R, Hardison H, Marks H, Legido A. Goldenthal MJ, et al. Biomark Med. 2015;9(10):957-65. doi: 10.2217/bmm.15.72. Epub 2015 Oct 6. Biomark Med. 2015. PMID: 26439018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters